Plurify

We are shaping the future of stem cell therapies

  • Biotech
Therapeutics

Member

Active

Status

2023

Founded

Development stage

  • EngBio1
    Accelerate

Plurify is developing cutting-edge technology to enhance gene therapy production. Its unique platform removes unwanted cells - one of the major bottlenecks and risks in cell therapy manufacture - by harnessing deep analytics to pinpoint these impurities with extreme precision. This creates a new ‘plurified’ product enabling the production of more efficient and affordable stem cell therapies at scale.